ARTICLE | Top Story

Merck, Simcere JV fallout

February 7, 2015 2:08 AM UTC

A high-profile China joint venture formed in 2011 between Simcere Pharmaceutical Group (Nanjing, China) and Merck & Co. Inc. (NYSE:MRK) appears to be coming to an end, with Simcere taking over management of SMSD (Shanghai) Ltd.

In a joint statement sent to BioCentury, the companies said that "in order to pursue further development and better meet challenges posed by the rapidly changing external environment, SMSD will undergo a strategy transformation." Under Simcere's management, SMSD will "focus on local innovative and mature products, serving the local market." ...